Brief: Immupharma PLC Reports FY Loss For Period Of £3.8M

ImmuPharma

11/05/2023 07:46

May 11 (Reuters) - ImmuPharma PLC  IMM.L :
    * IMMUPHARMA PLC - FY LOSS FOR PERIOD OF £3.8M
    * IMMUPHARMA PLC - CASH BALANCE AT 31 DECEMBER 2022 OF £0.7M
    * IMMUPHARMA PLC - HAVE A CLINICAL ROADMAP FOR LUPUZOR™ AND REMAIN ON TRACK
TO
COMMENCE PHASE 2/3 ADAPTIVE TRIAL IN H2 2023
    * IMMUPHARMA PLC - FY DILUTED LOSS PER SHARE 1.26P

Source text for Eikon:  ID:nRSK0214Za 
Further company coverage:  IMM.L 

 ((Reuters.Briefs@thomsonreuters.com;))